Dermatology

Eight JAK inhibitors are approved by the FDA to treat autoimmune, inflammatory, and allergic conditions.

A new survey found that neither generation is particularly good at maintaining healthy sun habits, and have low skin cancer awareness.

Dupilumab monotherapy plus concomitant topical corticosteroids can improve signs, symptoms, and patient health-related quality of life.

Dupilumab met both its primary and key secondary endpoints in a phase 3 trial, demonstrating efficacy as a potential treatment for atopic hand and foot dermatitis.

The combination of prednisone and methotrexate provided nearly complete or complete hair regrowth in up to 31.2% of patients with alopecia areata.

The FDA agreed to review a supplemental Biologics License Application for Opdivo to treat stage 2B or C, fully resected melanoma.

The safety of gel manicures is under renewed scrutiny after a new study suggested they can cause DNA damage

Convatec’s InnovaBurn is the first product of its kind intended to help patients manage burns and wounds.

The PDFUA date for the drug is October 13, 2023.

The once-daily, triple-combination gel led to a marked reduction in moderate to severe acne.

Previous surveys suggested care disparities. Investigators compared these outcomes because of a lack of research in this space.

Linda Stein Gold, MD explains in nonsteroidal treatment options for plaque psoriasis.

Biologics coordinators help patients access crucial medications.

The relationship between dermatology and social media was analyzed in a poster presentation during SBS 2023 in Miami, Florida.

The FDA approved a supplemental NDA for abrocitinib (Cibinqo) for adolescents with atopic dermatitis.

A phase 2 study of povorcitinib demonstrated sustained and durable efficacy after 1 year of treatment.

This year will be an exciting one for dermatologic therapy and pharmacology as treatments continue to evolve.

Long, hot showers and cold, dry air can contribute to psoriasis flare-ups during the winter months.

Highly effective medications for severe disease are expensive and administered invasively, while the development of treatments for milder disease has lagged, a new review on psoriasis clinical trials concludes.

Natasha A. Mesinkovska, MD, PhD, shares what’s new in alopecia areata management.

Recommendations were made for patients to help relieve inflammation, itching and infections.

Patients are finding relief in alternative therapies for this chronic skin disease.

Patients with psoriasis seem to suffer more in the wintertime when flare-ups are much more common.

Take a look back at our most popular dermatology coverage for 2022.

Skin of color can require different treatment options for atopic dermatitis.